Skip to main content

Table 2 Hazard ratios of mortality according to baseline variables in HBV-infected patients starting antiviral treatment in Ethiopia (n = 276)

From: Predictors of mortality in patients under treatment for chronic hepatitis B in Ethiopia: a prospective cohort study

Baseline variables

Unadjusted

P

Adjusted

P

HR (95% CI)

HR (95% CI)

Sex (male vs. female)

1.44 (0.60–3.48)

0.413

Age (years)

1.03 (1.00–1.06)

0.106

1.06 (1.02–1.10)

0.007

ALT (≥80 U/L vs. < 80 U/L)

1.19 (0.46–3.06)

0.722

BMI (< 18.5 kg/m2 vs. > 18.5 kg/m2)

2.84 (1.43–5.62)

0.003

3.65 (1.73–7.72)

0.001

Transient elastography (kPa)

  < 8.0

1

 

N/D a

 

  8.0–9.9

1.29 (0.08–20.57)

0.859

 

  ≥ 10.0

9.06 (1.24–66.43)

0.030

Cirrhosis assessment

 No cirrhosis

1

 

1

 

 Compensated cirrhosis

1.12 (0.07–17.95)

0.935

0.89 (0.06–14.42)

0.937

 Decompensated cirrhosis

28.10 (3.84–205.51)

0.001

23.68 (3.23–173.48)

0.002

  1. aTransient elastography could not be included in the adjusted model because of a strong correlation with one of the other variables
  2. HR hazard ratio, CI confidence interval, ALT alanine aminotransferase, BMI body mass index